TD Asset Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-187,788
| Closed | -$6.01M | – | 1435 |
|
|
2024
Q3 | $6.01M | Buy |
187,788
+13,600
| +8% | +$435K | 0.01% | 755 |
|
|
2024
Q2 | $4.71M | Buy |
174,188
+33,400
| +24% | +$903K | ﹤0.01% | 776 |
|
|
2024
Q1 | $3.04M | Buy |
140,788
+46,766
| +50% | +$1.01M | ﹤0.01% | 898 |
|
|
2023
Q4 | $567K | Sell |
94,022
-27,400
| -23% | -$165K | ﹤0.01% | 1283 |
|
|
2023
Q3 | $675K | Buy |
121,422
+72,811
| +150% | +$405K | ﹤0.01% | 1219 |
|
|
2023
Q2 | $357K | Buy |
48,611
+11,000
| +29% | +$80.7K | ﹤0.01% | 1311 |
|
|
2023
Q1 | $148K | Hold |
37,611
| – | – | ﹤0.01% | 1392 |
|
|
2022
Q4 | $119K | Hold |
37,611
| – | – | ﹤0.01% | 1411 |
|
|
2022
Q3 | $135K | Hold |
37,611
| – | – | ﹤0.01% | 1420 |
|
|
2022
Q2 | $116K | Sell |
37,611
-13
| -0% | -$40 | ﹤0.01% | 1408 |
|
|
2022
Q1 | $195K | Sell |
37,624
-13,226
| -26% | -$68.5K | ﹤0.01% | 1433 |
|
|
2021
Q4 | $246K | Sell |
50,850
-6,425
| -11% | -$31.1K | ﹤0.01% | 1441 |
|
|
2021
Q3 | $510K | Buy |
57,275
+40,282
| +237% | +$359K | ﹤0.01% | 1385 |
|
|
2021
Q2 | $153K | Hold |
16,993
| – | – | ﹤0.01% | 1494 |
|
|
2021
Q1 | $277K | Buy |
+16,993
| New | +$277K | ﹤0.01% | 1453 |
|